Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Economic analysis

Cost-utility analysis of lenvatinib and sorafenib for the first-line treatment of unresectable hepatocellular carcinoma in Vietnam: Evidence from a lower-middle income country

Thang Xuan Do, Ha Thi Nguyen, Phuong Thi Lan Nguyen, Mai Thi Tuyet Kieu, Tuan Viet Duong, Van Nu Hanh Pham

published 03 Apr 2026

Loading metrics information...

Metrics unavailable. Please check back later.

HiMSC and EV derived treatments increase Quality of Life and reduce amount of Knee Replacement Surgeries compared to current standard of care for knee osteoarthritis patients in The Netherlands

Iris W. A. Boot, Georgina Shaw, Yolande F. M. Ramos, Mary Murphy, Ingrid Meulenbelt, Hubertus J. M. Vrijhoef, on behalf of the AutoCRAT consortium

published 26 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-utility and budget impact analyses of significant fibrosis detection in individuals with metabolic syndrome or obesity in Thailand

Chayanis Kositamongkol, Pichaya Tantiyavarong, Alissa Ratanatawan, Pimsiri Sripongpun, Prawej Mahawithitwong, Prawat Kositamongkol, Surasak Saokaew, Pochamana Phisalprapa

published 23 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Comparative analysis of the impact of chickenpox and herpes zoster vaccination in Belgium under two different exogenous boosting mechanisms

James Wambua, John C. Lang, Benson Ogunjimi, Niel Hens, Philippe Beutels

published 19 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Biodiversity risks and corporate innovation: Evidence from China

Yongjian Lin, Zhicheng Song

published 18 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

ESG disclosure quality and firm valuation under economic policy uncertainty: Evidence from Chinese A-share listed firms

Chia-Hsien Tang, Feifei Luo

published 18 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness of percutaneous patent foramen ovale closure versus medical therapy for cryptogenic stroke prevention: A Chinese healthcare perspective

Chen Chen, Ting Xu, Zhujun Zeng, Jing Miao, Rong Hu, Yiming Gao, Chunlin Li, Meng Li, Xiaoli Yang

published 17 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

A cost-effective breast cancer screening strategy for Urban China: Findings from a Shenzhen-based modeling study

Changqing Tu, Yuke Zhong, Huan Li, Haifeng Qi, Qian Lu, Xuesen He

published 12 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Economic evaluation of anti-malarial drug policies across presidential regimes in Nigeria: A comparative analysis from 1999 to present

Chukwuka Elendu

published 11 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Investment modeling for scalable agricultural learning

Norman Peter Reeves, Rebecca Pietrelli, Ian Brooks, Victor G. Sal y Rosas Celi, Kumpati Narendra, Jean C. Ngabitsinze, Maximo Torero Cullen, Anne N. Lutomia, John W. Medendorp, Julia M. Bello-Bravo, Barry R. Pittendrigh

published 10 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness of sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer in China

Shuo Kang, Shuo Yang, Yize Jia, Shan Zhao

published 06 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness analysis of artificial intelligence-assisted risk stratification of indeterminate pulmonary nodules

Caroline M. Godfrey, Ashley A. Leech, Kevin C. McGann, Jinyi Zhu, Hannah N. Marmor, Sophia Pena, Lyndsey C. Pickup, Fabien Maldonado, Evan C. Osmundson, Stacie B. Dusetzina, Eric L. Grogan, Stephen A. Deppen

published 05 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness of primary HPV genotyping and dual-stain or cytology reflex testing versus cytology-based screening for cervical cancer in Chile

Nicolas Armijo, Manuel A. Espinoza, Pilar Contreras-Montiel, Macarena Vera, Carlos Balmaceda

published 04 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Economic analysis

You can change these options by clicking profile then "Alerts and Notifications"